期刊文献+

瑞舒伐他汀钙对老年2型糖尿病合并缺血性脑卒中患者颈动脉硬化、血脂、hs-CRP疗效分析 被引量:9

Analysis of the efficacy of rosuvastatin on carotid atherosclerotic plaques,lipid and high-sensitivity CRP in patients with elderly type 2 diabetic and ischemic stroke
下载PDF
导出
摘要 目的前瞻性观察瑞舒伐他汀钙对老年2型糖尿病(Type 2Diabetes Mellitus,T2DM)合并缺血性脑卒中患者颈动脉硬化、血脂、hs-CRP的疗效,为老年T2DM合并缺血性脑卒中的二级预防提供更多的临床证据。方法将我院老年T2DM合并急性ICVD患者226例,随机分成2组:(1)治疗组:瑞舒伐他汀钙片5mg/d+阿司匹林肠溶片0.1g/d+降糖药;(2)对照组:洛伐他汀胶囊20mg/d+阿司匹林肠溶片0.1g/d+降糖药,检测基线及入组后6月、12月、24月时的血浆hsCRP和血脂等各项指标,同时做颈动脉彩色多普勒超声检测基线及入组后6月、12月、24月时颈动脉内—中膜厚度(IMT)。结果在入组后6月、12月、24月时,治疗组的血浆hs-CRP和血脂水平低于对照组(P<0.05);2组在入组后6月、12月、24月时,2组的颈动脉彩色多普勒超声检测指标均优于入院时的基线水平,有显著性差异和极显著性差异(P<0.05,P<0.01);在入组后12月、24月时治疗组的超声检测指标优于对照组,有显著性差异和极显著性差异(P<0.05,P<0.01)。结论瑞舒伐他汀钙片可显著降低老年T2DM合并缺血性脑卒中患者的血脂、hs-CRP,并有逆转颈动脉粥样硬化斑块的作用,且疗效明显优于洛伐他汀胶囊,为老年T2DM合并急性ICVD的防治提供理论依据。 Objective To prospectively study of the effect of rosuvastatin on carotid atherosclerotic plaques ,lipid and high-sensitivity CRP (hs-CRP) in patients with elderly type 2 diabetic and ischemic stroke ,and to provide evidence for clinical practice on the secondary prevention of stroke.Methods Two hundred and twenty-six cases of elderly type 2 diabetes mellitus (T2DM ) and acute ICVD from the hospitalized patients were randomly divided into two groups :(1)the treatment group ,108 cases received the treatment of rosuvastatin 5 mg (qn) + aspirin 100 mg (qd) and antidiabetic drug ;(2) the control group , 113 cases received the treatment of luofastatin 20 mg (qn) + aspirin 100 mg (qd) and antidiabetic drug.The serum levels of hs-CRP and lipids of all patients were measured before and 6 months ,12 months and 24 months after treatment ,at the same period ,carotid intimae-media thickness (IMT) was measured with color Doppler ultrasound .Results Compared with the control group ,the level of hs-CRP and lipids decreased significantly at 6 months ,12 months and 24 months after the treatment of rosu-vastatin (P〈0.05). Compared with that before treatment ,IMT of the both group decreased at 6 months ,12 months and 24 months after the treatment (P〈0.05) ,and it decreased significantly at 12 months and 24 months after the treatment of rosuv-astatin (P〈0.01). Conclusion Rosuvastatin can obviously decrease the level of hs-CRP and lipids in patients with elderly type 2 diabetic and ischemic stroke ,and reversing the carotid atherosclerotic plaque ,and the curative effect is obviously superior tolovastatin capsules.
作者 裘丽红
出处 《中国实用神经疾病杂志》 2014年第10期25-27,共3页 Chinese Journal of Practical Nervous Diseases
关键词 老年2型糖尿病合并缺血性脑卒中 颈动脉粥样硬化 血脂 HS-CRP Elderly type 2 diabetic Ischemic stroke Carotid atherosclerotic plaques Lipid~ hs-CRP
  • 相关文献

参考文献13

二级参考文献95

共引文献33137

同被引文献66

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部